A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive ...

The 32-year-old former child star reflected on how far she's come in the past five years as she shared a sweet video on Wednesday.

Ozempic side effects are a hot topic but don’t panic – our experts are here to help. Here’s what to expect and how to ...

New animal research being presented at the European Congress on Obesity (ECO25) in Malaga, Spain (11–14 May), reveals ...

A systematic review published in JAMA Psychiatry looks at weight loss drugs (GLP-1 receptor agonists) and mental health. Prof Stella Chan, Charlie Waller Chair in Evidence-based Psychological ...

Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

According to a recent study, glucagon-like peptide-1 receptor agonists are associated with a reduction in alcohol intake.

Weekly jabs might not sound glamorous, but Mounjaro and Ozempic are making headlines for more than just managing blood sugar.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

Recent research shows combining weight loss with blood sugar control is even more effective for reducing health risks ...

Q1 2025 Earnings Call Transcript May 13, 2025Fractyl Health, Inc. Common Stock reports earnings inline with expectations.